(Q37063833)

18 August 2017

1 reference

title

Fatigue in palliative care patients -- an EAPC approach (English)

1 reference

18 August 2017

0 references

6

Stein Kaasa

0 references

Patrick C. Stone

object named as

Patrick Stone

8

0 references

Lukas Radbruch

1

object named as

Lukas Radbruch

1 reference

18 August 2017

Florian Strasser

2

1 reference

18 August 2017

Frank Elsner

3

1 reference

18 August 2017

Jose Ferraz Gonçalves

4

1 reference

18 August 2017

Jon Løge

5

1 reference

18 August 2017

Friedemann Nauck

7

1 reference

18 August 2017

Research Steering Committee of the European Association for Palliative Care (EAPC)

9

1 reference

18 August 2017

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

22

1 reference

18 August 2017

1

1 reference

18 August 2017

13-32

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

18 August 2017

1 reference

Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Prevention and treatment of cancer cachexia: new insights into an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A phase II study of methylphenidate for the treatment of fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue in patients with advanced cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The measurement, causes and effective management of cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Symptoms and suffering at the end of life in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue associated with multiple sclerosis: diagnosis, impact and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue in multiple sclerosis: definition, pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Palliative care for end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue in ambulatory AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Assessment and treatment of HIV-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Investigation of diagnostic criteria for cancer-related fatigue syndrome in patients with advanced cancer: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The biologic basis of fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Tired, weak, or in need of rest: fatigue among general practice attenders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Population based study of fatigue and psychological distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A new way of thinking about fatigue: a reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Validation of the German version of the brief fatigue inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Cancer cachexia and fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Symptom clusters: the new frontier in symptom management research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Occurrence of symptom clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue and proinflammatory cytokine activity in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

High level of fatigue in lymphoma patients treated with high dose therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue associated with cancer and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Diurnal cortisol rhythm and fatigue in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The role of cytokines in cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue in cancer patients is not related to changes in oxyhaemoglobin dissociation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Cetuximab therapy and symptomatic hypomagnesemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue, depression and quality of life in cancer patients: how are they related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Lentiviral infection, immune response peptides and sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A Phase III Study of Recombinant Human Interferon Gamma to Prevent Opportunistic Infections in Advanced HIV Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Fatigue in HIV-infected men receiving investigational interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Growth hormone, fatigue, poor sleep, and disability in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Origin of symptoms in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Twenty years of research on cytokine-induced sickness behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The assessment of fatigue: a practical guide for clinicians and researchers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

MIDOS--validation of a minimal documentation system for palliative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Driving ability under long-term treatment with transdermal fentanyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Thalidomide: a new anticancer drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Managing cancer-related anaemia with epoetin alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Cancer- and treatment-related anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Cancer-associated malnutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Clinical management of anorexia and cachexia in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Appetite and cancer-associated anorexia: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Effects of parenteral hydration in terminally ill cancer patients: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Evidence-based treatment for cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Review of exercise intervention studies in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The effect of a physical exercise program in palliative care: A phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Feasibilty of a sleep intervention during adjuvant breast cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Psychotherapy during radiotherapy: effects on emotional and physical distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Relaxation therapy as an adjunct in radiation oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

An environmental intervention to restore attention in women with newly diagnosed breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Psychostimulants in supportive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A phase II study of methylphenidate for depression in advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Methylphenidate hydrochloride for excessive daytime sleepiness in a patient with myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Modafinil treatment of opioid-induced sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Treating fatigue in patients with MS: one step forward, one step back

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

Pentoxifylline therapy in HIV seropositive subjects with elevated TNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307085183

21 January 2018

Identifiers

DOI

10.1177/0269216307085183

1 reference

18 August 2017

1 reference